Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Neoplasms, Skull Base

fluorodeoxyglucose f18 has been researched along with Neoplasms, Skull Base in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's11 (84.62)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alongi, P; Del Vecchio, A; Di Muzio, N; Gerevini, S; Gianolli, L; Iaccarino, L; Losa, M; Mortini, P; Perani, D; Plebani, V1
Abergel, A; Abu-Ghanem, S; Fliss, DM; Ghanayem, M; Yafit, D; Yehuda, M1
Ahrweiller, F; Castelli, J; Cuvilliers, C; Palard-Novello, X; Vauléon, E1
Badakhshi, H; Budach, V; Graf, R; Prasad, V1
Mizuno, Y; Saginoya, T; Tomura, N1
Cestari, DM; Leskov, I; Rasool, N1
Inoue, A; Kohno, S; Nishida, N; Nishikawa, M; Ohnishi, T; Ohue, S1
Chen, YK; Hsieh, TC; Kao, CH; Liang, JA; Lin, YY; Sun, SS; Wang, CH; Wu, YC; Yen, KY1
Fujimaki, M; Hanaguri, M; Ikeda, K; Ito, S; Kazuo, K; Ohba, S; Yazawa, M; Yokoyama, J; Yoshimoto, H1
Clemenceau, S; Ferrand, R; Feuvret, L; George, B; Habrand, JL; Kerrou, K; Lot, G; Mammar, H; Mazure, N; Mokhtari, K; Nataf, V; Polivka, M; Pontvert, D; Pouysségur, J; Talbot, JN1
Aghi, MK; El-Sayed, IH; Jahangiri, A; Jian, B; Miller, L1
Conrad, GR; Holzhauer, M; Sinha, P1
Glenn, LW1

Reviews

3 review(s) available for fluorodeoxyglucose f18 and Neoplasms, Skull Base

ArticleYear
Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature.
    World neurosurgery, 2016, Volume: 91

    Topics: Adolescent; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bone Density Conservation Agents; Cranial Fossa, Posterior; Denosumab; Endoscopy; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Nose; Positron-Emission Tomography; Skull Base Neoplasms; Sphenoid Bone; Tomography, X-Ray Computed

2016
Skull base chordomas: clinical features, prognostic factors, and therapeutics.
    Neurosurgery clinics of North America, 2013, Volume: 24, Issue:1

    Topics: Biomarkers, Tumor; Chondrosarcoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neurosurgical Procedures; Positron-Emission Tomography; Postoperative Complications; Prognosis; Skull Base Neoplasms; Survival; Tomography, X-Ray Computed

2013
Innovations in neuroimaging of skull base pathology.
    Otolaryngologic clinics of North America, 2005, Volume: 38, Issue:4

    Topics: Angiography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skull Base Neoplasms; Tomography, X-Ray Computed

2005

Trials

2 trial(s) available for fluorodeoxyglucose f18 and Neoplasms, Skull Base

ArticleYear
PET Evaluation of Late Cerebral Effect in Advanced Radiation Therapy Techniques for Cranial Base Tumors.
    Current radiopharmaceuticals, 2018, Volume: 11, Issue:2

    Topics: Brain; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Meningioma; Neuropsychological Tests; Pituitary Neoplasms; Positron-Emission Tomography; Radiosurgery; Skull Base Neoplasms

2018
Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.
    International journal of radiation oncology, biology, physics, 2012, Nov-01, Volume: 84, Issue:3

    Topics: Adult; Cell Hypoxia; Chordoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Skull Base Neoplasms; Tomography, X-Ray Computed; Young Adult

2012

Other Studies

8 other study(ies) available for fluorodeoxyglucose f18 and Neoplasms, Skull Base

ArticleYear
Utility of first positron emission tomography-computed tomography scan as a prognostic tool following treatment of sinonasal and skull base malignancies.
    Head & neck, 2019, Volume: 41, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paranasal Sinus Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Skull Base Neoplasms; Survival Rate; Treatment Outcome; Whole Body Imaging; Young Adult

2019
FDG PET in Diffuse Spinal Carcinomatous Meningitis.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:6

    Topics: Aged; Brain; Fluorodeoxyglucose F18; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Meningeal Carcinomatosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skull Base Neoplasms; Spinal Cord Neoplasms

2019
The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2014, Jun-25, Volume: 14

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiosurgery; Radiotherapy, Image-Guided; Skull Base Neoplasms; Tomography, X-Ray Computed

2014
PET/CT findings for tumors in the base of the skull: comparison of 18 F-FDG with 11 C-methionine.
    Acta radiologica (Stockholm, Sweden : 1987), 2016, Volume: 57, Issue:3

    Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Skull Base; Skull Base Neoplasms; Tomography, X-Ray Computed

2016
Hypometabolic Lateral Recti Due to Bilateral Cranial Nerve VI Palsy.
    JAMA ophthalmology, 2015, Volume: 133, Issue:9

    Topics: Abducens Nerve Diseases; Carcinoma; Carcinoma, Papillary; Esotropia; Fluorodeoxyglucose F18; Humans; Middle Aged; Oculomotor Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Skull Base Neoplasms; Thyroid Cancer, Papillary; Thyroid Neoplasms

2015
Exposing the evil in the dark: the usefulness of delayed-phase FDG PET scan to enhance the detectability of tiny residual skull base osteosarcoma initially concealed by adjacent high physiological brain activity.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:8

    Topics: Brain; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Osteosarcoma; Positron-Emission Tomography; Sensitivity and Specificity; Skull Base Neoplasms; Time Factors; Tomography, X-Ray Computed

2010
Usefulness of Choline-PET for the detection of residual hemangiopericytoma in the skull base: comparison with FDG-PET.
    Head & face medicine, 2012, Feb-07, Volume: 8

    Topics: Choline; Fluorodeoxyglucose F18; Hemangiopericytoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skull Base Neoplasms

2012
Perineural spread of skin carcinoma to the base of the skull: detection with FDG PET and CT fusion.
    Clinical nuclear medicine, 2004, Volume: 29, Issue:11

    Topics: Aged; Carcinoma, Squamous Cell; Cranial Nerve Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Skull Base Neoplasms; Tomography, X-Ray Computed; Trigeminal Nerve

2004